Agilent Technologies, Inc. (NYSE:A) Shares Sold by Swedbank AB

Swedbank AB decreased its position in Agilent Technologies, Inc. (NYSE:A) by 0.8% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 146,228 shares of the medical research company’s stock after selling 1,233 shares during the quarter. Swedbank AB’s holdings in Agilent Technologies were worth $19,644,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in A. Creative Planning boosted its holdings in shares of Agilent Technologies by 0.3% during the second quarter. Creative Planning now owns 42,412 shares of the medical research company’s stock worth $5,498,000 after purchasing an additional 118 shares during the last quarter. NewEdge Advisors LLC grew its holdings in Agilent Technologies by 17.9% in the 2nd quarter. NewEdge Advisors LLC now owns 18,347 shares of the medical research company’s stock valued at $2,378,000 after buying an additional 2,782 shares during the period. Northwestern Mutual Wealth Management Co. grew its holdings in Agilent Technologies by 14.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 2,858 shares of the medical research company’s stock valued at $370,000 after buying an additional 366 shares during the period. Truist Financial Corp lifted its holdings in shares of Agilent Technologies by 0.9% during the 2nd quarter. Truist Financial Corp now owns 38,345 shares of the medical research company’s stock worth $4,971,000 after acquiring an additional 350 shares during the period. Finally, Cetera Investment Advisers lifted its holdings in shares of Agilent Technologies by 23.8% during the 2nd quarter. Cetera Investment Advisers now owns 40,485 shares of the medical research company’s stock worth $5,248,000 after acquiring an additional 7,791 shares during the period.

Analyst Ratings Changes

Several equities analysts recently commented on the stock. Sanford C. Bernstein dropped their price target on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research report on Tuesday, November 26th. Bank of America cut their target price on Agilent Technologies from $153.00 to $150.00 and set a “neutral” rating on the stock in a research report on Friday, December 13th. Barclays lowered their price target on Agilent Technologies from $145.00 to $135.00 and set an “underweight” rating for the company in a research report on Wednesday, November 27th. Wells Fargo & Company cut their price objective on Agilent Technologies from $157.00 to $155.00 and set an “overweight” rating on the stock in a report on Monday, December 9th. Finally, JPMorgan Chase & Co. decreased their target price on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, November 26th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and eight have issued a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $143.62.

Insider Buying and Selling at Agilent Technologies

In other Agilent Technologies news, CEO Padraig Mcdonnell sold 1,911 shares of the firm’s stock in a transaction on Tuesday, January 21st. The shares were sold at an average price of $150.00, for a total transaction of $286,650.00. Following the completion of the transaction, the chief executive officer now directly owns 39,652 shares of the company’s stock, valued at $5,947,800. This trade represents a 4.60 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website.

Agilent Technologies Stock Up 0.2 %

Shares of NYSE:A opened at $151.75 on Friday. The company has a market capitalization of $43.34 billion, a price-to-earnings ratio of 34.33, a price-to-earnings-growth ratio of 3.98 and a beta of 1.06. The company has a 50 day moving average of $140.16 and a two-hundred day moving average of $138.65. Agilent Technologies, Inc. has a 52-week low of $124.16 and a 52-week high of $155.35. The company has a quick ratio of 1.58, a current ratio of 2.09 and a debt-to-equity ratio of 0.57.

Agilent Technologies (NYSE:A) last released its quarterly earnings results on Monday, November 25th. The medical research company reported $1.46 earnings per share for the quarter, beating analysts’ consensus estimates of $1.41 by $0.05. Agilent Technologies had a net margin of 19.80% and a return on equity of 25.43%. The business had revenue of $1.70 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period last year, the business earned $1.38 EPS. The business’s revenue was up .8% on a year-over-year basis. As a group, analysts forecast that Agilent Technologies, Inc. will post 5.56 earnings per share for the current fiscal year.

Agilent Technologies Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 22nd. Investors of record on Tuesday, December 31st were issued a $0.248 dividend. The ex-dividend date was Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a yield of 0.65%. This is an increase from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s dividend payout ratio is currently 22.40%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.